Retracted: Long Noncoding RNA TP73-AS1 Targets MicroRNA-329-3p to Regulate Expression of the SMAD2 Gene in Human Cervical Cancer Tissue and Cell Lines.

The Editors of Medical Science Monitor wish to inform you that the above manuscript has been retracted from publication due to concerns with the credibility and originality of the study, the manuscript content, and the Figure images. Reference: Mei Mei Guan, Qun Xian Rao, Miao Ling Huang, Li Juan Wang, Shao Dan Lin, Qing Chen, Chang Hao Liu. Long Noncoding RNA TP73-AS1 Targets MicroRNA-329-3p to Regulate Expression of the SMAD2 Gene in Human Cervical Cancer Tissue and Cell Lines. Med Sci Monit, 2019; 25: 8131-8141. DOI: 10.12659/MSM.916292.

Promising traditional Chinese medicine for the treatment of cholestatic liver disease process (cholestasis, hepatitis, liver fibrosis, liver cirrhosis).

ETHNOPHARMACOLOGICAL RELEVANCE: Cholestatic liver disease (CLD) is mainly characterized by cholestasis. If not treated, it will deteriorate to cholestatic hepatitis, liver fibrosis, liver cirrhosis, and even liver failure. CLD has a high clinical incidence, and limited treatment with single therapy. In the long-term clinical exploration, traditional Chinese medicine (TCM) has been corroborated with unique therapeutic effects on the CLD process. AIM OF THIS REVIEW: This paper summarizes the effective single and compound TCMs for the treatment of CLD. According to 4 important clinical stages of CLD: cholestasis, hepatitis, liver fibrosis, liver cirrhosis, pharmacological effects and mechanisms of 5 typical TCM examples are reviewed, aims to provide basis for clinical drug selection in different processes of CLD. MATERIALS AND METHODS: Relevant scientific articles regarding therapeutic effects of TCM for the CLD were collected from different databases. We collated three single herbs including Artemisia scoparia Waldst. et Kit. or Artemisia capillaris Thunb. (Artemisiae Scopariae Herba, Yin Chen in Chinese), Paeonia lactiflora Pall. or Paeonia veitchii Lynch. (Paeoniae radix rubra, Chi Shao in Chinese), Poria cocos (Schw.) Wolf (Poria, Fu Ling in Chinese), and two compound herbs of Huang Qi Decoction (HQD) and Yin Chen Hao Decoction (YCHD) to studied and analyzed. RESULTS: We proposed five promising TCMs treatments for the important developmental stages of CLD. Among them, Yin Chen is an essential medicine for protecting liver and gallbladder, and its TCM prescription is also a promising strategy for cholestasis. Based on clinical evidence, high-dose application of Chi Shao is a clinical special treatment of cholestasis hepatitis. Fu Ling can regulate immune cells and increase antibody levels in serum, which is expected to be an emerging therapy to prevent cholestatic liver fibrosis to cirrhosis. HQD can be used as routine clinical medicine for liver fibrosis. In addition, YCHD can exert better comprehensive advantages with multiple components, can treat the whole course of CLD and prevent it from developing to the end-stage. CONCLUSION: Yin Chen, Chi Shao, Fu Ling, HQD and YCHD have shown good clinical efficacy in controlling the development of CLD. Clinically, it is easier to curb the development of CLD by adopting graded diagnosis and treatment measures. We suggest that CLD should be risk stratified in clinical treatment to ensure personalized treatment for patients, so as to slow down the development of the disease.

Population Structure of Blue Marlin, Makaira nigricans, in the Pacific and Eastern Indian Oceans.

Hui Chen, Chia-Hao Chang, Chi-Lu Sun, Kwang-Tsao Shao, Su-Zan Yeh, and Gerard DiNardo (2016) Blue marlin Makaira nigricans is economically important for fisheries worldwide. However, overfishing has substantially reduced the stock size. Better knowledge of blue marlin population genetics will help improve management and conservation. Previous genetic studies concluded that the Pacific blue marlin should be considered a single stock. This study investigated the population genetic structure of blue marlin inhabiting the Pacific and eastern Indian oceans based on mtDNA cytochrome b (cyt b) and control region (CR) sequence variation. We collected tissue samples (n = 183) from three Pacific and one Indian Ocean, and determined the sequences of 1140 bp of cyt b and 905 bp of CR. Phylogenetic analysis revealed that blue marlin contain two clades, the Atlantic clade and the ubiquitous clade, and that all the eastern Indian and Pacific individuals collected for this study belonged to the ubiquitous clade. All eastern Indian and Pacific blue marlin possess extremely high haplotype diversity (h) and low nucleotide diversity (π). The results of pairwise ΦST, hierarchical analysis of molecular variance (AMOVA) and spatial analysis of molecular variance (SAMOVA) all support that there is no population differentiation among eastern Indian and Pacific blue marlin. Neutrality tests and pairwise mismatch distribution analysis both indicated that eastern Indian and Pacific blue marlin have undergone a rapid population expansion on the order of 0.30 to 0.65 million years ago (mya). This study demonstrates that blue marlin in the Pacific and eastern Indian oceans constitute a single stock. International cooperation will be required to preserve blue marlin as a resource; moreover, the high genetic variation of blue marlin in this region suggests that unique haplotypes in the population are sensitive to high harvesting levels and could disappear.